Christian Rohlff
Chief Executive Officer Oxford BioTherapeutics Ltd
Seminars
Tuesday 13th October 2026
Laying Out Case Study Investigation of Novel Target Pairings to Strive Beyond Classic Combinations & Elevate Bispecific ADC Therapeutic Potential
3:00 pm
- Conducting a landscape review of bispecific ADC targets, highlighting the commonality of target pairings based on previous clinical activity
- Emphasizing the importance and opportunity of bispecific target pairing beyond historically validated combinations
- Exploring case study investigations of novel bispecific target pairs driven by rationale to combine efficacy without additional safety concerns
